Doctors John DeGuire and Ryan Lapour, Eye Surgeon specialists at Pacific ClearVision Institute in Eugene, Oregon, are engaging in an ongoing Sodium Hyaluronate study in an effort to relieve dry eye symptoms.
An estimated 20 million people globally have dry eye, and more than 3.2 million American women, aged 50 or older, suffer from chronic dry eye.
Among dry eye patients over the age of 65 in the US, 73% visited their eye care professional within the previous year for their dry eye condition, and Restasis had over $1.5 billion in sales between 2003 to 2008.
The local community is allowed participation in this ALCON sponsored study.
Folks must meet the following critera:
1. Male and female adults aged 18 years and over.
2. Women should not plan to become pregnant during the course of the study. Women should plan to use adequate birth control methods for the duration of the study.
3. Patients must have at least a 3 month documented history of dry eye in both eyes diagnosed as dry eye syndrome, keratoconjunctivitis sicca (KCS), or due to Sjögren’s Syndrome (immune exocrinopathy).
4. Patients must have all of the following criteria in the same eye at both the Screening and Baseline visits: At least 2 symptoms of dry eye (soreness, scratchiness, dryness, grittiness, and burning)
5. Patients must agree to discontinue all artificial tears from Screening through the duration of the treatment period (Screening to Day 14).
6. Patients who have taken Restasis® are eligible for inclusion if they have not used Restasis during the 4 weeks prior to Screening.
For more information contact Pacific ClearVision Institute at 541-343-5000.
